Hindustan Agrigenetics Board of Directors

Get the latest insights into the leadership at Hindustan Agrigenetics. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Pranav Kapur Chairman
Mr. Pritam Kapur Managing Director
Ms. Chandni Kapur Director & CFO
Ms. Mannu Kohli Independent Director
Mr. Sunny Srivastava Independent Director
Mr. Naren Parsai Independent Director

Hindustan Agrigenetics Share price

HINDUST

67.4

0.10 (-0.15%)
Last updated on 4 Sep, 2025 | 15:27 IST
BUYSELL
Today's High

68.50

Today's Low

65.00

52 Week Low

47.37

52 Week High

103.00

The current prices are delayed, login to your account for live prices

Hindustan Agrigenetics FAQs

The board at Hindustan Agrigenetics consists of experienced professionals, including Mr. Pranav Kapur , Mr. Pritam Kapur , and others, overseeing the company’s strategic and corporate governance.

Directors at Hindustan Agrigenetics are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Pranav Kapur is the current chairman at Hindustan Agrigenetics.

Executive directors at Hindustan Agrigenetics are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Hindustan Agrigenetics adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Hindustan Agrigenetics, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.